Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group (Q33541101)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group |
scientific article |
Statements
1 reference
Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group (English)
1 reference
P Schöffski
1 reference
G Catimel
1 reference
A S Planting
1 reference
J P Droz
1 reference
J Verweij
1 reference
D Schrijvers
1 reference
L Gras
1 reference
A Schrijvers
1 reference
J Wanders
1 reference
A R Hanauske
1 reference
1 January 1999
1 reference
1 reference
Identifiers
1 reference